- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRC introduces new PowerScribe
MRC introduces new PowerScribeThe MRC Group unveiled version 2.0 of its PowerScribe for Radiology speech recognition offering at the 1998 Healthcare Information & Management Systems Society (HIMSS) annual meeting. The new version features
MRC introduces new PowerScribe
The MRC Group unveiled version 2.0 of its PowerScribe for Radiology speech recognition offering at the 1998 Healthcare Information & Management Systems Society (HIMSS) annual meeting. The new version features real-time, workstation-based speech recognition, as well as server-based speech recognition, which maximizes system performance and radiologist acceptance, according to the Cleveland-based company.
Available now, version 2.0 also enables radiologists to dictate and edit the report immediately, according to the firm. In addition, radiologists can navigate and edit their reports by voice. Current PowerScribe for Radiology customers will be upgraded free of charge. MRC developed the PowerScribe family of products in partnership with Articulate Systems of Woburn, MA.
- Search again
- Homepage
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
